| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 280,801 | 258,040 | 276,626 | 166,634 | | Cost of Revenue | 59,387 | 216,273 | 213,715 | 223,304 | | | Gross Profit | 221,414 | 41,767 | 62,911 | (56,670) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 205,689 | 150,738 | 69,447 | 81,887 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 16,315 | (10,826) | 41,560 | 14,433 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (590) | (98,145) | (48,096) | (152,990) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 82,954 | (82,954) | (599,118) | | Earnings Before Interest And Taxes | 131,595 | (98,145) | (48,096) | (152,990) | | Interest Expense | 31,472 | 32,384 | 33,387 | 36,130 | | Income Before Tax | 100,123 | (130,529) | (81,483) | (189,120) | | Income Tax Expense | 1,680 | 29,127 | (24,304) | 1,971,489 | | Minority Interest | 619 | 165 |
-
|
-
| | | | Net Income From Continuing Ops | 345,610 | 411,149 | (140,133) | (2,759,727) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 43,886 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 370,199 | 411,149 | (140,133) | (2,715,841) | | Preferred Stock And Other Adjustments |
-
| (126) | 126 |
-
| | | Net Income Applicable To Common Shares | $370,199 | $411,023 | ($140,007) | ($2,715,841) |
|
1.52% Nasdaq 
Income Statement
